… In addition to our evaluation of different assays for SARS-CoV-2 detection, we also show
that it is possible to significantly increase capacity for the RNA extraction step of SARS-CoV-2 …

… A novel coronavirus of zoonotic origin (2019-nCoV) has … This virus is genetically similar to
SARS coronavirus and bat SARS… analysis indicated that 2019-nCoV is a distinct clade from the …

… The specificity of our assay was determined by evaluating its … than SARS-CoV-2. Taken
together, these results showed that our newly developed assay was highly specific for SARS-CoV…

… Since the beginning of the outbreak, clinical laboratories have been developing various
assays to aid in detecting SARS-CoV-2 and clinically managing patients with COVID-19. …

… Here, we assessed the usefulness of the Novaplex™ SARS-CoV-2 Variants I Assay kit in …
kit and discuss its implications in the differential identification of SARS-CoV-2 variants. …

… SARS-CoV-2 RNA detection kits in the present study. The assessment of commercial kits in
… ., As a result of time to market, not all kits have satisfied with China CDC standards or been …

… three SARS-CoV-2-specific commercial ELISA assays and six POC rapid tests were evaluated
using sera from hospitalized adult patients with PCR-confirmed diagnoses for SARS-CoV-…

… the production capacity for these assays is far too low. SARS-CoV-2 specific antigen assays,
a simple and fast alternative for nucleic acid amplification assays, have become available …

… SARS-CoV-2 IgG/IgM Kit), while some are based on colloidal gold immunoassays (Assay
Genie COVID-19 rapid POC kit and VivaDiag™ SARS-CoV-2 IgM/IgG rapid test). A summary …

… In this comparison of the RealStar® SARS-CoV-2 assay with the reference WHO assay, we
observed a slightly better sensitivity of the RealStar® assay. It provides a robust option for all …